NCT00485680View on ClinicalTrials.gov

Olanzapine Versus Comparator in the Treatment of Bipolar Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

June 30, 2005

Conditions

Bipolar Disorder

Interventions

DRUG

Olanzapine Hydrochloride

DRUG

Lithium Carbonate

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Shanghai

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00485680 - Olanzapine Versus Comparator in the Treatment of Bipolar Disorder | Biotech Hunter | Biotech Hunter